All In MedTech

Company

Inogen

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

INGN

Nasdaq · Inogen Inc

Public float

$190M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$349M

Fiscal year ending Dec 31, 2025

Net income

-$22.7M

Fiscal year ending Dec 31, 2025

R&D spending

$19.4M

Fiscal year ending Dec 31, 2025

Cash

$81.8M

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

26.0M

As of Oct 29, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$27.2M––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Feb 16, 2010Equity$9.6M$10.0M8Rule 506Form D/A ↗Jul 13, 20101 amendment

Company details

From the company's latest Form D.

Legal name
Inogen Inc
Headquarters
Goleta, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    6 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Inogen we have 2 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    2 more trials with a free account

    Reports received

    415

    Received Nov 1, 2025 to Nov 19, 2026

    Malfunction reports

    31

    7.5% of reports

    Injury reports

    380

    92% of reports

    Death reports

    4

    1.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 235100
    Jan 247100
    Feb 244200
    Mar 241000
    Apr 240000
    May 240000
    Jun 242000
    Jul 2425120
    Aug 2410000
    Sep 245000
    Oct 246010
    Nov 247000
    Dec 246000
    Jan 257020
    Feb 2511000
    Mar 2547400
    Apr 2521600
    May 250800
    Jun 2512100
    Jul 2511800
    Aug 25111100
    Sep 2511100
    Oct 2531100
    Nov 2511900
    Dec 2501100
    Jan 2611900
    Feb 2601410
    Mar 2613510
    Apr 2644600
    May 2602800
    Jun 2623210
    Jul 2634100
    Aug 26114200
    Sep 2634100
    Oct 2655210
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    • Z-1368-05 · Started Aug 1, 2005 · Posted by FDA Aug 12, 2005

      Reason given: Firm plans to upgrade all units to correct situations that could lead to interuption in oxygen delivery.

      Cause as FDA categorized it: Other · Device type: Generator, Oxygen, Portable (CAW)

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.